Medicare Enrolled
Dr. Joel Grossman, MD
Medical Oncology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Grossman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grossman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Grossman
Dr. Joel Grossman is a medical oncology in Naples, FL, with 19 years in practice. Based on federal Medicare data, Dr. Grossman performed 227,409 Medicare services across 4,668 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grossman received a total of $22,783 from 85 pharmaceutical and/or device companies across 1172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grossman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 11% volume in FL$ $22,783 industry payments
Medicare Practice Summary
Medicare Utilization ↗227,409
Medicare services
Top 11% in FL for medical oncology
4,668
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11,969 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 119,850 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 17,420 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 16,550 | $6 | $23 |
| Pembrolizumab injection (Keytruda) | 15,400 | $43 | $137 |
| Immune globulin infusion (Gammagard) | 11,672 | $36 | $108 |
| Injection, mepolizumab, 1 mg | 8,700 | $23 | $72 |
| Denosumab injection (Prolia/Xgeva) | 8,520 | $18 | $51 |
| Paclitaxel chemotherapy injection | 7,780 | $0 | $2 |
| Complete blood count (CBC) with differential | 3,117 | $8 | $29 |
| Blood draw (venipuncture) | 2,823 | $8 | $9 |
| Dexamethasone injection (steroid) | 2,732 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,840 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,586 | $11 | $69 |
| Office visit, established patient (30-39 min) | 1,496 | $99 | $339 |
| Office visit, established patient (20-29 min) | 1,046 | $68 | $239 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 712 | $1 | $6 |
| Injection, fluorouracil, 500 mg | 665 | $2 | $7 |
| Administration of chemotherapy into vein, 1 hour or less | 492 | $103 | $378 |
| Injection of additional new drug or substance into vein | 483 | $12 | $61 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 376 | $50 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 363 | $16 | $56 |
| Anti-nausea injection (ondansetron/Zofran) | 348 | $0 | $9 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 342 | $23 | $84 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 310 | $3 | $205 |
| Injection, carboplatin, 50 mg | 230 | $2 | $41 |
| Office visit, established patient, complex (40-54 min) | 223 | $140 | $474 |
| Injection of drug or substance into vein | 187 | $29 | $156 |
| Injection, diphenhydramine hcl, up to 50 mg | 183 | $1 | $3 |
| Injection, magnesium sulfate, per 500 mg | 174 | $1 | $2 |
| Administration of chemotherapy into vein, each additional hour | 163 | $22 | $79 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 139 | $27 | $89 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 138 | $18 | $59 |
| Injection, zoledronic acid, 1 mg | 136 | $7 | $69 |
| Administration of additional new drug or substance into vein, 1 hour or less | 135 | $52 | $178 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 121 | $134 | $562 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 113 | $56 | $206 |
| Red blood count automated, with additional calculations | 102 | $5 | $20 |
| Infusion, normal saline solution , 1000 cc | 97 | $2 | $7 |
| Administration of additional new drug or substance into vein using push technique | 88 | $45 | $170 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 72 | $131 | $637 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 68 | $16 | $56 |
| Infusion into a vein for hydration, 31-60 minutes | 63 | $26 | $156 |
| Automated urinalysis | 62 | $2 | $8 |
| Infusion into a vein for hydration, each additional hour | 59 | $10 | $42 |
| New patient office visit, complex (60-74 min) | 53 | $176 | $585 |
| Drawing of blood for a medical problem | 49 | $72 | $277 |
| New patient office visit (30-44 min) | 49 | $84 | $298 |
| New patient office visit (45-59 min) | 44 | $121 | $453 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 22 | $141 | $467 |
| Red blood count, automated test | 16 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
58.5% high complexity
37.3% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,783
Total received (2018-2024)
Avg $3,255/year across 7 years
Top 22% in FL for medical oncology
85
Companies
1,172
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,946 (96.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$837 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,297
2023$3,937
2022$3,782
2021$3,454
2020$2,906
2019$2,095
2018$2,314
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$2,034
E.R. Squibb & Sons, L.L.C.
$1,449
Novartis Pharmaceuticals Corporation
$1,379
Celgene Corporation
$1,181
Genentech USA, Inc.
$1,103
Janssen Biotech, Inc.
$1,062
Incyte Corporation
$1,024
Merck Sharp & Dohme Corporation
$990
Amgen Inc.
$930
Merck Sharp & Dohme LLC
$916
GENZYME CORPORATION
$806
AstraZeneca Pharmaceuticals LP
$667
Seagen Inc.
$641
Regeneron Healthcare Solutions, Inc.
$629
BeiGene USA, Inc.
$460
GlaxoSmithKline, LLC.
$454
Myriad Genetic Laboratories, Inc.
$415
Astellas Pharma US Inc
$388
Daiichi Sankyo Inc.
$368
ARRAY BIOPHARMA INC
$367
Lilly USA, LLC
$353
Gilead Sciences, Inc.
$278
Eisai Inc.
$274
Kite Pharma, Inc.
$260
Foundation Medicine, Inc.
$242
Takeda Pharmaceuticals U.S.A., Inc.
$239
Alexion Pharmaceuticals, Inc.
$202
ABBVIE INC.
$161
EISAI INC.
$144
Pharmacyclics LLC, an AbbVie Company
$143
SOBI, INC
$125
Bayer HealthCare Pharmaceuticals Inc.
$124
Janssen Scientific Affairs, LLC
$120
SERVIER PHARMACEUTICALS LLC
$119
EMD Serono, Inc.
$114
ADC Therapeutics America, Inc.
$114
Kyowa Kirin, Inc.
$112
Karyopharm Therapeutics Inc.
$105
Pharmacyclics LLC, An AbbVie Company
$101
Boehringer Ingelheim Pharmaceuticals, Inc.
$101
PharmaEssentia USA Corporation
$100
CTI BioPharma Corp.
$98
Jazz Pharmaceuticals Inc.
$95
Rigel Pharmaceuticals, Inc.
$90
Bayer Healthcare Pharmaceuticals Inc.
$81
AbbVie Inc.
$78
Sobi, Inc
$77
Puma Biotechnology, Inc.
$74
Spectrum Pharmaceuticals Inc.
$73
Exelixis Inc.
$73
JAZZ PHARMACEUTICALS INC.
$73
Deciphera Pharmaceuticals Inc.
$66
Dendreon Pharmaceuticals LLC
$59
MorphoSys, US Inc.
$58
Taiho Oncology, Inc.
$57
AbbVie, Inc.
$56
Dova Pharmaceuticals
$55
Stemline Therapeutics Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$51
Myovant Sciences Inc.
$50
Agios Pharmaceuticals, Inc.
$48
Sirtex Medical Inc
$47
AVEO Pharmaceuticals, Inc.
$46
Pharmacosmos Therapeutics Inc.
$45
Aurobindo Pharma USA, Inc.
$44
Acrotech Biopharma Inc.
$41
Epizyme, Inc.,
$40
Partner Therapeutics, Inc.
$39
TerSera Therapeutics LLC
$35
Genmab U.S., Inc.
$27
Heron Therapeutics, Inc.
$25
Fennec Pharmaceuticals, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$23
Aveo Pharmaceuticals, Inc.
$22
GE HealthCare
$21
Alnylam Pharmaceuticals Inc.
$21
Mirati Therapeutics, Inc.
$20
Helsinn Therapeutics (U.S.), Inc.
$18
TAIHO ONCOLOGY, INC.
$17
Sumitomo Pharma America, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$15
Acrotech Biopharma LLC
$14
Acceleron Pharma, Inc.
$13
NanoString Technologies, Inc.
$12
Veracyte, Inc.
$2
Top 3 companies account for 21.3% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ADVATE · AFINITOR · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRACAnalysis · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · Enhertu · Epkinly · Erivedge · Erleada · FOTIVDA · FOUNDATIONONE · Fabhalta · Folotyn · GAMMAGARD · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Imbruvica · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kovaltry · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lunsumio · MARQIBO · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYCHOICE CDX · MYLOTARG · MYRISK · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Reblozyl · Revlimid · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · ZYTIGA · Zevalin · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $10 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
10
Per 100K population
2.6
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Grossman is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Grossman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Grossman performed 119,850 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grossman receive payments from pharmaceutical companies?
Yes. Dr. Grossman received a total of $22,783 from 85 companies across 1,172 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grossman's costs compare to other medical oncologys in Naples?
Dr. Grossman's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grossman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Naples
Browse medical oncologys in Naples ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology